
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 27, 2023, titled "Cosmo and Glenmark announce the signing of Distribution and License Agreementsfor Winlevi�� in Europe and South Africa".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 27, 2023, titled "Cosmo and Glenmark announce the signing of Distribution and License Agreementsfor Winlevi�� in Europe and South Africa".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals